2
|
Sinha N, Duncan JS, Diehl B, Chowdhury FA, de Tisi J, Miserocchi A, McEvoy AW, Davis KA, Vos SB, Winston GP, Wang Y, Taylor PN. Intracranial EEG Structure-Function Coupling and Seizure Outcomes After Epilepsy Surgery. Neurology 2023; 101:e1293-e1306. [PMID: 37652703 PMCID: PMC10558161 DOI: 10.1212/wnl.0000000000207661] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Accepted: 06/02/2023] [Indexed: 09/02/2023] Open
Abstract
BACKGROUND AND OBJECTIVES Surgery is an effective treatment for drug-resistant epilepsy, which modifies the brain's structure and networks to regulate seizure activity. Our objective was to examine the relationship between brain structure and function to determine the extent to which this relationship affects the success of the surgery in controlling seizures. We hypothesized that a stronger association between brain structure and function would lead to improved seizure control after surgery. METHODS We constructed functional and structural brain networks in patients with drug-resistant focal epilepsy by using presurgery functional data from intracranial EEG (iEEG) recordings, presurgery and postsurgery structural data from T1-weighted MRI, and presurgery diffusion-weighted MRI. We quantified the relationship (coupling) between structural and functional connectivity by using the Spearman rank correlation and analyzed this structure-function coupling at 2 spatial scales: (1) global iEEG network level and (2) individual iEEG electrode contacts using virtual surgeries. We retrospectively predicted postoperative seizure freedom by incorporating the structure-function connectivity coupling metrics and routine clinical variables into a cross-validated predictive model. RESULTS We conducted a retrospective analysis on data from 39 patients who met our inclusion criteria. Brain areas implanted with iEEG electrodes had stronger structure-function coupling in seizure-free patients compared with those with seizure recurrence (p = 0.002, d = 0.76, area under the receiver operating characteristic curve [AUC] = 0.78 [95% CI 0.62-0.93]). Virtual surgeries on brain areas that resulted in stronger structure-function coupling of the remaining network were associated with seizure-free outcomes (p = 0.007, d = 0.96, AUC = 0.73 [95% CI 0.58-0.89]). The combination of global and local structure-function coupling measures accurately predicted seizure outcomes with a cross-validated AUC of 0.81 (95% CI 0.67-0.94). These measures were complementary to other clinical variables and, when included for prediction, resulted in a cross-validated AUC of 0.91 (95% CI 0.82-1.0), accuracy of 92%, sensitivity of 93%, and specificity of 91%. DISCUSSION Our study showed that the strength of structure-function connectivity coupling may play a crucial role in determining the success of epilepsy surgery. By quantitatively incorporating structure-function coupling measures and standard-of-care clinical variables into presurgical evaluations, we may be able to better localize epileptogenic tissue and select patients for epilepsy surgery. CLASSIFICATION OF EVIDENCE This is a Class IV retrospective case series showing that structure-function mapping may help determine the outcome from surgical resection for treatment-resistant focal epilepsy.
Collapse
Affiliation(s)
- Nishant Sinha
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada.
| | - John S Duncan
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Beate Diehl
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Fahmida A Chowdhury
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Jane de Tisi
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Anna Miserocchi
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Andrew William McEvoy
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Kathryn A Davis
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Sjoerd B Vos
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Gavin P Winston
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Yujiang Wang
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| | - Peter Neal Taylor
- From the Department of Neurology (N.S., K.A.D.), Penn Epilepsy Center, Perelman School of Medicine, and Center for Neuroengineering and Therapeutics (N.S., K.A.D.), University of Pennsylvania, Philadelphia; Translational and Clinical Research Institute (Y.W., P.N.T.), Faculty of Medical Sciences, and Computational Neuroscience, Neurology, and Psychiatry Lab (Y.W., P.N.T.), ICOS Group, School of Computing, Newcastle University; Department of Epilepsy (J.S.D., B.D., F.A.C., J.d.T., A.M., A.W.M., G.P.W., Y.W., P.N.T.), UCL Queen Square Institute of Neurology; UCL Centre for Medical Image Computing (S.B.V.); Neuroradiological Academic Unit (S.B.V.), UCL Queen Square Institute of Neurology, London; MRI Unit (J.S.D., G.P.W.), Chalfont Centre for Epilepsy, Bucks, United Kingdom; Centre for Microscopy, Characterisation, and Analysis (S.B.V.), The University of Western Australia, Nedlands; and Division of Neurology (G.P.W.), Department of Medicine, Queen's University, Kingston, Canada
| |
Collapse
|
5
|
Gleichgerrcht E, Munsell BC, Alhusaini S, Alvim MKM, Bargalló N, Bender B, Bernasconi A, Bernasconi N, Bernhardt B, Blackmon K, Caligiuri ME, Cendes F, Concha L, Desmond PM, Devinsky O, Doherty CP, Domin M, Duncan JS, Focke NK, Gambardella A, Gong B, Guerrini R, Hatton SN, Kälviäinen R, Keller SS, Kochunov P, Kotikalapudi R, Kreilkamp BAK, Labate A, Langner S, Larivière S, Lenge M, Lui E, Martin P, Mascalchi M, Meletti S, O'Brien TJ, Pardoe HR, Pariente JC, Xian Rao J, Richardson MP, Rodríguez-Cruces R, Rüber T, Sinclair B, Soltanian-Zadeh H, Stein DJ, Striano P, Taylor PN, Thomas RH, Elisabetta Vaudano A, Vivash L, von Podewills F, Vos SB, Weber B, Yao Y, Lin Yasuda C, Zhang J, Thompson PM, Sisodiya SM, McDonald CR, Bonilha L. Artificial intelligence for classification of temporal lobe epilepsy with ROI-level MRI data: A worldwide ENIGMA-Epilepsy study. Neuroimage Clin 2021; 31:102765. [PMID: 34339947 PMCID: PMC8346685 DOI: 10.1016/j.nicl.2021.102765] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2021] [Revised: 07/15/2021] [Accepted: 07/17/2021] [Indexed: 01/22/2023]
Abstract
Artificial intelligence has recently gained popularity across different medical fields to aid in the detection of diseases based on pathology samples or medical imaging findings. Brain magnetic resonance imaging (MRI) is a key assessment tool for patients with temporal lobe epilepsy (TLE). The role of machine learning and artificial intelligence to increase detection of brain abnormalities in TLE remains inconclusive. We used support vector machine (SV) and deep learning (DL) models based on region of interest (ROI-based) structural (n = 336) and diffusion (n = 863) brain MRI data from patients with TLE with ("lesional") and without ("non-lesional") radiographic features suggestive of underlying hippocampal sclerosis from the multinational (multi-center) ENIGMA-Epilepsy consortium. Our data showed that models to identify TLE performed better or similar (68-75%) compared to models to lateralize the side of TLE (56-73%, except structural-based) based on diffusion data with the opposite pattern seen for structural data (67-75% to diagnose vs. 83% to lateralize). In other aspects, structural and diffusion-based models showed similar classification accuracies. Our classification models for patients with hippocampal sclerosis were more accurate (68-76%) than models that stratified non-lesional patients (53-62%). Overall, SV and DL models performed similarly with several instances in which SV mildly outperformed DL. We discuss the relative performance of these models with ROI-level data and the implications for future applications of machine learning and artificial intelligence in epilepsy care.
Collapse
Affiliation(s)
| | - Brent C Munsell
- Department of Psychiatry, University of North Carolina at Chapel Hill, NC, USA; Department of Computer Science, University of North Carolina at Chapel Hill, NC, USA
| | - Saud Alhusaini
- Neurology Department, Yale University School of Medicine, New Haven, CT, USA; Department of Molecular and Cellular Therapeutics, The Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Marina K M Alvim
- Department of Neurology and Neuroimaging Laboratory, University of Campinas - UNICAMP, Campinas, SP, Brazil
| | - Núria Bargalló
- Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain; Department of Radiology of Center of Image Diagnosis (CDIC), Hospital Clinic de Barcelona, Barcelona, Spain
| | - Benjamin Bender
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany
| | - Andrea Bernasconi
- Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Neda Bernasconi
- Neuroimaging of Epilepsy Laboratory, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Boris Bernhardt
- McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Karen Blackmon
- Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA
| | - Maria Eugenia Caligiuri
- Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - Fernando Cendes
- Department of Neurology and Neuroimaging Laboratory, University of Campinas - UNICAMP, Campinas, SP, Brazil
| | - Luis Concha
- Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico
| | - Patricia M Desmond
- Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
| | - Orrin Devinsky
- Department of Neurology, Langone School of Medicine, New York University, New York, NY, USA
| | - Colin P Doherty
- Trinity College Dublin, School of Medicine, Dublin, Ireland; FutureNeuro SFI Research Centre for Rare and Chronic Neurological Diseases, Dublin, Ireland
| | - Martin Domin
- Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany
| | - John S Duncan
- Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK
| | - Niels K Focke
- University Medicine Göttingen, Clinical Neurophysiology, Göttingen, Germany
| | - Antonio Gambardella
- Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy; Institute of Neurology, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - Bo Gong
- Department of Radiology, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada
| | - Renzo Guerrini
- Neuroscience Department, University of Florence, Florence, Italy
| | - Sean N Hatton
- Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA
| | - Reetta Kälviäinen
- Kuopio University Hospital, Member of EpiCARE ERN, Kuopio, Finland; Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio, Finland
| | - Simon S Keller
- Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK; The Walton Centre NHS Foundation Trust, Liverpool, UK
| | - Peter Kochunov
- Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA
| | - Raviteja Kotikalapudi
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Tübingen, Germany; Department of Clinical Neurophysiology, University Hospital Göttingen, Goettingen, Germany; Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany
| | - Barbara A K Kreilkamp
- University Medicine Göttingen, Clinical Neurophysiology, Göttingen, Germany; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK
| | - Angelo Labate
- Neuroscience Research Center, Department of Medical and Surgical Sciences, University "Magna Græcia" of Catanzaro, Catanzaro, Italy; Institute of Neurology, University "Magna Græcia" of Catanzaro, Catanzaro, Italy
| | - Soenke Langner
- Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany; Institute for Diagnostic and Interventional Radiology, Pediatric and Neuroradiology, University Medical Centre Rostock, Rostock, Germany
| | - Sara Larivière
- McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Matteo Lenge
- Pediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Children's Hospital A. Meyer-University of Florence, Florence, Italy; Functional and Epilepsy Neurosurgery Unit, Neurosurgery Department, Children's Hospital A. Meyer-University of Florence, Florence, Italy
| | - Elaine Lui
- Department of Radiology, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
| | - Pascal Martin
- Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Tübingen, Germany
| | - Mario Mascalchi
- 'Mario Serio' Department of Clinical and Experimental Medica Sciences, University of Florence, Florence, Italy
| | - Stefano Meletti
- Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy
| | - Terence J O'Brien
- Department of Neuroscience, Monash University, Melbourne, VIC, Australia; The Department of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Parkville, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| | - Heath R Pardoe
- Department of Neurology, Langone School of Medicine, New York University, New York, NY, USA
| | - Jose C Pariente
- Magnetic Resonance Image Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
| | - Jun Xian Rao
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | | | - Raúl Rodríguez-Cruces
- Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, Mexico; Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada
| | - Theodor Rüber
- Department of Epileptology, University Hospital Bonn, Bonn, Germany
| | - Ben Sinclair
- Department of Neuroscience, Monash University, Melbourne, VIC, Australia; The Department of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Parkville, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| | - Hamid Soltanian-Zadeh
- Radiology and Research Administration, Henry Ford Health System, Detroit, MI, USA; School of Electrical and Computer Engineering, College of Engineering, University of Tehran, Tehran, Iran
| | - Dan J Stein
- SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry & Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Pasquale Striano
- IRCCS Istituto 'G. Gaslini', Genova, Italy; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy
| | - Peter N Taylor
- Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy; School of Computing, Newcastle University, Newcastle Upon Tyne, UK
| | - Rhys H Thomas
- Institute of Translational and Clinical Research, Newcastle University, Newcastle Upon Tyne, UK
| | - Anna Elisabetta Vaudano
- Department of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Neurology Unit, OCB Hospital, AOU Modena, Modena, Italy
| | - Lucy Vivash
- Department of Neuroscience, Monash University, Melbourne, VIC, Australia; The Department of Medicine (The Royal Melbourne Hospital), The University of Melbourne, Parkville, VIC, Australia; Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| | - Felix von Podewills
- Department of Neurology, Epilepsy Center, University Medicine Greifswald, Greifswald, Germany
| | - Sjoerd B Vos
- Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK
| | - Bernd Weber
- Institute of Experimental Epileptology and Cognition Research, University of Bonn, Bonn, Germany
| | - Yi Yao
- Institute of Experimental Epileptology and Cognition Research, University of Bonn, Bonn, Germany
| | - Clarissa Lin Yasuda
- Department of Neurology and Neuroimaging Laboratory, University of Campinas - UNICAMP, Campinas, SP, Brazil
| | - Junsong Zhang
- Cognitive Science Department, School of Informatics, Xiamen University, Xiamen, China
| | - Paul M Thompson
- Imaging Genetics Center, Mark and Mary Stevens Institute for Neuroimaging and Informatics, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA
| | - Sanjay M Sisodiya
- UCL Queen Square Institute of Neurology, London, UK; Chalfont Centre for Epilepsy, Bucks, UK
| | - Carrie R McDonald
- Department of Psychiatry, University of California San Diego, La Jolla, CA, USA
| | - Leonardo Bonilha
- Department of Neurology, Medical University of South Carolina, Charleston, SC, USA
| |
Collapse
|